Research map: Gout is independently associated with occult hepatic fibro-inflammation independent of obesity: a multi-cohort study using MRI-cT1 and elastography

Back to the article

Papers in this map

  1. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age · Cathie L. M. Sudlow · 2015 · 13948 citations · Cited by this paper
  2. Clinical trial endpoints for metabolic dysfunction and alcohol associated steatotic liver disease · 2026 · Related
  3. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes · Zobair M. Younossi · 2015 · 11046 citations · Cited by this paper
  4. APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update · 2026 · Related
  5. Sensitivity Analysis in Observational Research: Introducing the E-Value · Tyler J. VanderWeele · 2017 · 6320 citations · Cited by this paper
  6. APASL STC on Wilson Disease; New Delhi 2026 · 2026 · Related
  7. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease · Laurent Castéra · 2019 · 1518 citations · Cited by this paper
  8. Tolvaptan for hyponatremia in patients with cirrhosis: a post hoc subgroup analysis of a multicenter, randomized, double-blind, placebo-controlled trial · 2026 · Related
  9. Non-invasive evaluation of liver fibrosis using transient elastography · Laurent Castéra · 2008 · 1438 citations · Cited by this paper
  10. Phosphatidylethanol versus clinical criteria to diagnose alcohol use relapse after liver transplantation: a prospective cohort study · 2026 · Related
  11. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease · Peter J. Eddowes · 2019 · 1435 citations · Cited by this paper
  12. Precision medicine for G-CSF in ACLF: the biomarker gap · 2026 · Related
  13. From NASH to HCC: current concepts and future challenges · Quentin Mark Anstee · 2019 · 1432 citations · Cited by this paper
  14. Response to letter to editor—Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon · 2026 · Related
  15. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors · Mats Dehlin · 2020 · 1412 citations · Cited by this paper
  16. Methodological Considerations in the MAFLD-MASLD Dichotomy for Cardiac Risk Assessment · 2026 · Related
  17. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis · Thomas Karlas · 2016 · 1283 citations · Cited by this paper
  18. Obstructive sleep apnea mediates the association between body mass index and metabolic dysfunction-associated steatotic liver disease in patients with obesity · 2026 · Related
  19. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries · Paul Yien Kwo · 2016 · 1234 citations · Cited by this paper
  20. Gout · Nicola Dalbeth · 2016 · 1111 citations · Cited by this paper
  21. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease · Thomas Jensen · 2018 · 951 citations · Cited by this paper
  22. Uric acid transport and disease · Alexander K.-L. So · 2010 · 875 citations · Cited by this paper
  23. Determination of reliability criteria for liver stiffness evaluation by transient elastography · Jérôme Boursier · 2012 · 660 citations · Cited by this paper
  24. Inflammation in gout: mechanisms and therapeutic targets · Alexander K.-L. So · 2017 · 623 citations · Cited by this paper
  25. A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer · Takuma Tsuchida · 2018 · 590 citations · Cited by this paper
  26. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials · Mazen Noureddin · 2013 · 552 citations · Cited by this paper
  27. Soluble Uric Acid Activates the NLRP3 Inflammasome · Tárcio Teodoro Braga · 2017 · 449 citations · Cited by this paper
  28. Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes · Yea-Jin Choi · 2014 · 294 citations · Cited by this paper
  29. Association of serum uric acid level with non-alcoholic fatty liver disease: A cross-sectional study · Youming Li · 2009 · 274 citations · Cited by this paper
  30. Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care · Hyon K. Choi · 2021 · 126 citations · Cited by this paper
  31. Associations between an inflammatory diet index and severe non-alcoholic fatty liver disease: a prospective study of 171,544 UK Biobank participants · Fanny Emily Petermann-Rocha · 2023 · 111 citations · Cited by this paper
  32. BayesGmed: An R-package for Bayesian causal mediation analysis · Belay Birlie Yimer · 2023 · 36 citations · Cited by this paper
  33. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women · P. J. Liu · 2014 · 21 citations · Cited by this paper
  34. Metabolic dysfunction associated fatty liver disease in healthy weight individuals · Nahúm Méndez‐Sánchez · 2024 · 16 citations · Cited by this paper
  35. Associations of serum uric acid levels with liver disease‐related morbidity and mortality: A prospective cohort study of the UK Biobank · Zhening Liu · 2023 · 6 citations · Cited by this paper
  36. Untitled · Cited by this paper
  37. Untitled · Cited by this paper

Source: OpenAlex (CC0)